Abstract
In the context of SARS-CoV-2 pandemic, the mechanical ventilation is essential. Given its limited availability due to high cost, increased by a global demand, sharing a single mechanical ventilator with 2 or more patients with has been advocated. We have designed an experimental model for ventilating 2 test lungs with a single equipment, in order to measure these possible asymmetries during ventilation in parallel circuits with different compliances. Quantitative results shown decreasing the distensibility of one of the test lungs resulted in smaller volume received than its counterpart in volume-controlled mode and pressure-controlled. By adding a restrictive element to one of them, we proved that volumes given to either test lungs are different, and that the maximum pressure increases in the volume-controlled mode. The volume difference is greater in pressure-controlled mode. This report attempts a first approach to the risks in ventilating 2 patients with single equipment, since there are differences in volumes which are not monitored by the ventilator, with the consequent risks of distension or alveolar collapse if used in real patients with different thoracopulmonary mechanics
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external financing was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This report was not carried out on humans, so it was not submitted to an ethics committee.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
I declare, represent the responsibility together with the three authors, on the good practice in the writing of the manuscript to present.
